Identification of ADAM23 as a Potential Signature for Psoriasis Using Integrative Machine-Learning and Experimental Verification
Article in International Journal of General Medicine (December 2023)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Uncovering a neurological protein signature for severe COVID-19
Article in Neurobiology of Disease (May 2023)
A novel program of infiltrative control in astrocytomas: ADAM23 depletion promotes cell invasion by activating γ-secretase complex
Article in Neuro-Oncology Advances (January 2023)